Riskpilot← Back to searchSign inGet full accessRedakliniken konsult AB
ABActiveOrg 5566621339Roxenbadenvägen 11Sports and recreation education · NACE 8551Est. 20040 employees
Revenue 2025
SEK 848K
+26% vs 2024
EBITDA margin
39.1%
+91% vs 2024
Equity ratio
45.0%
Financial strength
Net profit 2025
SEK 25K
+266% vs 2024
| Revenue | SEK 848K | +26% |
| EBITDA | SEK 331K | +91% |
| Net profit | SEK 25K | +266% |
| Total assets | SEK 460K | -40% |
| Equity | SEK 207K | +14% |
| Employees | 0 | — |
Legal name
Redakliniken konsult AB
Org number
5566621339
Legal form
Aktiebolag
NACE code
8551 · Sports and recreation education
Founded
10 maj 2004
Share capital
SEK 100 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolaget ska bedriva rådgivning, konsultationer och utbildning inom psykriatri och annan sjukvård samt fastighetsförvaltning och därtill hörande verksamheter.
Address
Roxenbadenvägen 11
Email
thomas@redakliniken.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 753 | 965 | 1 339 | 674 | 848 |
| Staff expenses | — | — | — | −123 | −142 |
| EBITDA | 352 | 510 | 985 | 173 | 331 |
| Depreciation & amort. | −0 | −0 | −0 | — | — |
| EBIT | 352 | 510 | 985 | 173 | 331 |
| Net financials | — | −1 | 2 | 18 | 5 |
| Profit before tax | 6 | 8 | 87 | 11 | 36 |
| Tax | −6 | −5 | −19 | −4 | −11 |
| Net profit | 0 | 3 | 68 | 7 | 25 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 489 | 353 | 944 | 764 | 460 |
| Equity | 104 | 107 | 175 | 182 | 207 |
| Long-term debt | 0 | 0 | 0 | 362 | 0 |
| Short-term debt | 386 | 246 | 769 | 220 | 253 |
| Total debt | 386 | 246 | 769 | 582 | 253 |
EBITDA margin
39.1%
This company
15.8%
Market median
+147% vs market
20212025
Equity ratio
45.0%
This company
38.2%
Market median
+18% vs market
20212025
Return on equity
12.1%
This company
18.4%
Market median
+34% vs market
20212025
Net profit margin
3.0%
This company
8.1%
Market median
-63% vs market
20212025
Asset turnover
1.85×
This company
1.12×
Market median
+65% vs market
20212025
Debt / equity
1.22×
This company
0.62×
Market median
-97% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
NP Chief Auditor | Chief Auditor | 2024 |
| Former (1) | ||
RK Chief Auditor | Chief Auditor | 2022 – 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2022 | |
| Chairman | 2022 | |
| Board of Directors | 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
REDAKLINIKEN AB
Redakliniken konsult AB Board members of Redakliniken konsult AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Nils Peter Broomé | Chief Auditor | 0 companies |
| Rolf Kraff | Chief Auditor | 0 companies |
| Matts Peter Markus Schenck | Board of Directors | 0 companies |
| Erik Thomas Eriksson | Chairman | 0 companies |
| Malin Sofia Kjellqvist | Board of Directors | 0 companies |